To further evaluate the value of FRAS1/FREM in predicting the prognosis of KIRC cancer patients, the association between FRAS1, FREM1 and FREM2 expression and overall survival (OS), disease-specific survival (DSS) and progression-free survival (PFS) was analyzed using TCGA. The gene discussed is FRAS1; the disease is cancer.